arrow
A

Alexander Biederstädt

The University of Texas MD Anderson Cancer Center
H指数:12
被引数:1,415

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency

全基因组CRISPR筛选鉴定出增强CAR-NK细胞抗肿瘤效力的关键靶点

2025-08-210
OAAI
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells

Rafei, H.; Basar, R.; Acharya, S.; Hsu, Y.-S.; Liu, P.; Zhang, D.; Bohn, T.; Liang, Q.; Mohanty, V.; Upadhyay, R.; 等. CREM是NK细胞中CAR和IL-15信号通路的调控检查点。Nature 2025, 643, 1076–1086. [Google Scholar] [CrossRef] [PubMed]

Nature
IF48.5
2025-06-040
OAAI
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML
2024-09-110
PRE
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024-07-223
PRE
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape (vol 28, pg 2133, 2022)
2024-01-050
OA
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
2022-09-2983
OA
Paclitaxel plus ramucirumab versus paclitaxel alone in patients with squamous-cell carcinoma of the esophagus, refractory or intolerant to combination therapy with fluoropyrimidine and platinum-based drugs - RAMOS, a randomized phase II trial of the German Gastric Group of the AIO
2020-09-011
OAAI